Improved CAR T-cells – Bispecific chimeric antigen receptors with a CD30 binding domain

Adoptive T-cell therapy is a very promising approach in the treatment of cancer. Early phase clinical trials with genetically engineered T-cells expressing a tumor-specific chimeric antigen receptor (CAR) show significant efficacy in the treatment. However, currently used CAR modified T-cells for antigen-directed targeting towards tumor cells have insufficient performance in the anti-tumor attack, e. g. less amplification and cytolytic activity after the transfer of the modified T-cells into the patient. Scientists from the University Medical Center of Cologne developed a bispecific CAR, which improves the performance of genetically engineered T-cells expressing these CAR polypeptides on their surface. The bispecific CAR comprises two antibody units, with one antibody unit being an anti-CD30 single chain antibody unit and the other antibody unit being an antibody unit specific for an antigen present on the surface of a predetermined target cell, e. g. for the tumor carcino-embryonic antigen (CEA) on breast cancer cells.

Further information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 10

Contact
Dipl.-Ing. Alfred Schillert

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

EEG ad tDCS chould serve as the basis of therapeutic strategies to combat newrological disorders. Image Credit: Institute of Science Tokyo

Using Electroencephalography to Improve Language Disorder Treatments

Researchers work towards an inexpensive and portable solution for treating aphasia  Electroencephalography (EEG) may offer a more accessible alternative to functional magnetic resonance imaging (fMRI) for guiding transcranial direct current…

The BioSCape team is poctured with NASA and South African aircraft. Image Credit: Jeremey Shelton/Fishwater Films

Measuring Life on Earth from Space: A Global Research Project

Measurements and data collected from space can be used to better understand life on Earth. An ambitious, multinational research project funded by NASA and co-led by UC Merced civil and…

NEJM study finds patients with blockages in medium-sized vessels in the brain who had endovascular treatment did not do any better and did not see any improvement compared to patients who had the standard of care. Dr. Michael Hill, MD, Dr. Mayank Goyal, MD, PhD (right). Image Credit: Riley Brandt, University of Calgary

Best Approach for Stroke in Medium-Sized Blood Vessels Identified

Calgary’s Stroke Program advancing science to improve care, treatment and outcomes for patients  University of Calgary’s Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized…